Diabetes Webcast Tower

Advert for Healthcare Professionals Only

I am a patient (Please go to our patient website)

Disease Topics
eCME
Webcasts
Knowledge Centres
Latest Drug Updates
Quick Search
All Drug Databases
Diabetes Webcast Leaderboard

Advert for Healthcare Professionals Only

Latest Drugs

Eye Health and Disorders Drug Data - A-Z (English)

Drug Class Description

Anti-inflammatories, non-steroid.

Generic Name

Nedocromil

Drug Description

Nedocromil sodium 2.0% w/v.

Presentation

Presented as a 5 ml sterile, preserved, aqueous solution containing 2% nedocromil sodium in a dropper bottle for administration to the eye.

Indications

For the prevention, relief and treatment of allergic conjunctivitis, including seasonal allergic conjunctivitis, allergic conjunctivitis and vernal-kerato conjunctivitis.

Adult Dosage

Adults (including the elderly) and children aged 6 years and over:

In seasonal allergic conjunctivitis: one drop into each eye twice daily, increasing when necessary to four times daily. In seasonal allergic conjunctivitis therapy should be restricted to 12 weeks.

In vernal kerato-conjunctivitis: one drop into each eye four times daily.

Adults (including the elderly):

In perennial allergic conjunctivitis: one drop into each eye twice daily, increasing when necessary to four times daily.

Rapitil should be used regularly to ensure optimum control of symptoms.

There is only limited clinical trial evidence with Rapitil in children aged below 6 years, therefore use in this age range cannot be recommended.

Child Dosage

Under 6 years, not recommended; over 6 years, same as adult. Not recommended for children in perennial allergic conjuctivitis.

Contra Indications

Contraindicated in patients with known hypersensitivity to any constituent of the formulation.

Special Precautions

Patients who use soft contact lenses should be advised not to wear them during the treatment period. In patients who continue to use hard or gas-permeable contact lenses during treatment with the eye drops, the lenses should be taken out of the eye prior to instillation and not inserted again for at least 10 minutes.

Interactions

None has been reported.

Adverse Reactions

Transient stinging and burning may occur after instillation. Other symptoms of local irritation have been reported rarely. Some patients have reported a distinctive taste.

Manufacturer

Aventis

Drug Availability

(POM)

Updated

21 May 2009
Drug Languages: en it fr de es no nl pt se

Forgotten password?

RAPITIL